603193 Stock Overview
Engages in the research, production, and sale of mosquito repellent products, baby care products, and essential oil products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Runben Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥17.35 |
| 52 Week High | CN¥26.68 |
| 52 Week Low | CN¥11.92 |
| Beta | 0 |
| 11 Month Change | 0.52% |
| 3 Month Change | -8.73% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -21.42% |
Recent News & Updates
Shareholder Returns
| 603193 | CN Personal Products | CN Market | |
|---|---|---|---|
| 7D | -4.1% | -0.5% | -1.4% |
| 1Y | n/a | -35.8% | -21.4% |
Return vs Industry: Insufficient data to determine how 603193 performed against the CN Personal Products industry.
Return vs Market: Insufficient data to determine how 603193 performed against the CN Market.
Price Volatility
| 603193 volatility | |
|---|---|
| 603193 Average Weekly Movement | 6.0% |
| Personal Products Industry Average Movement | 4.9% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.6% |
| 10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 603193 has not had significant price volatility in the past 3 months.
Volatility Over Time: 603193's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 917 | n/a | www.runben.com |
Runben Biotechnology Co., Ltd. engages in the research, production, and sale of mosquito repellent products, baby care products, and essential oil products. The company sells its products through online channels. Runben Biotechnology Co., Ltd.
Runben Biotechnology Co., Ltd. Fundamentals Summary
| 603193 fundamental statistics | |
|---|---|
| Market cap | CN¥7.05b |
| Earnings (TTM) | CN¥286.59m |
| Revenue (TTM) | CN¥1.20b |
24.5x
P/E Ratio5.9x
P/S RatioIs 603193 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603193 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.20b |
| Cost of Revenue | CN¥507.41m |
| Gross Profit | CN¥690.42m |
| Other Expenses | CN¥403.83m |
| Earnings | CN¥286.59m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.71 |
| Gross Margin | 57.64% |
| Net Profit Margin | 23.93% |
| Debt/Equity Ratio | 0% |
How did 603193 perform over the long term?
See historical performance and comparison